IRENE NARVIOS: Open Payments
NPI 1306207709 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 7 payments from 6 companies in 2025. Trend: 2023 $1,021 · 2024 $904 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $206 |
| Verastem, Inc. | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $87 |
| Eisai Inc. | 1 | $84 |
| PFIZER INC. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: Korlym, AVMAPKI FAKZYNJA CO-PACK, Epclusa, Leqembi, INLYTA, LIBTAYO.
Industry payments across TX — which companies pay providers there.
